|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61P 31/10 | |||
| C07K 14/47 |
| (11) | Patento numeris | 2717902 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12796397.3 |
| Europos patento paraiškos padavimo data | 2012-06-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-04-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/041092 |
| Data | 2012-06-06 |
| (87) | Numeris | WO 2012/170524 |
| Data | 2012-12-13 |
| (30) | Numeris | Data | Šalis |
| 201161493845 P | 2011-06-06 | US |
| (72) |
GEORGOPOULOS, Lynne, M., US
ARNOLD, Susan, US
|
| (73) |
Phasebio Pharmaceuticals, Inc.,
One Great Valley Parkway Suite 30, Malvern, Pennsylvania 19355,
US
|
| (54) | USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION |
| USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION |